- Home
- EPIX
EPIX
ESSA Pharma Inc.
as 12-17-2024 4:00pm EST
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
| Founded: | 2009 | Country: | Canada |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 73.5M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 286.3K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.40 - $11.67 | Next Earning Date: | 02-11-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of ESSA Pharma Inc. (EPIX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BIOTECH GROWTH N V | EPIX | 10% Owner | Nov 1 '24 | Sell | $1.53 | 7,879,583 | $12,018,409.08 | 5,879,583 | |
| Virsik Peter | EPIX | Chief Operating Officer | Oct 7 '24 | Sell | $6.03 | 694 | $4,184.82 | 7,776 |
Latest ESSA Pharma Inc. News
EPIX Breaking Stock News: Dive into EPIX Ticker-Specific Updates for Smart Investing
Associated Press Finance
a day ago
ESSA Pharma: Fiscal Q4 Earnings Snapshot
CNW Group
a day ago
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
Simply Wall St.
a month ago
ESSA Pharma And 2 Other US Penny Stocks To Watch
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 11/06/2024
Investing.com
a month ago
ESSA Pharma downgraded by Oppenheimer, Piper Sandler after drug setback in trials
MT Newswires
2 months ago
Sector Update: Health Care Stocks Rise Late Afternoon
MT Newswires
2 months ago
Top Midday Decliners
MT Newswires
2 months ago
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday
Compare EPIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EPIX ESSA Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.